摘要
通过对2019年版世界卫生组织基本药物目录的分析,重新认识基本药物的性质,在总结基本药物遴选原则和目录制定特点的基础上,提出对我国动态调整基本药物目录的启示:发挥药物经济学评价的作用、重视循证医学的证据、确保基本药物目录和医疗保险药品报销目录的衔接。
On the basis of the analysis of the WHO essential medicines model list in 2019,the nature of essential medicines has been re-recognized.Based on the summary of the principles of selecting essential medicines and the characteristics of list formulation,the enlighten-ment of dynamic adjustment of essential medicines list in China has been put forward,which plays a role of pharmacoeconomic evaluation and the importance to evidence-based medicine,and ensures the linkage between essential medicines list and medical insurance drug reimbursement list in the future.
作者
胡善联
HU Shan-lian(School of Public Health,Fudan University,Shanghai 200032,China)
关键词
基本药物目录
世界卫生组织
医疗保险药品报销目录
药物经济学评价
essential medicines model list
World Health Organization
medical insurance drug reimbursement list
pharmacoeconomic evaluation
